Skip to main content
Defiance International

Humanin Treatment Protects Against Venetoclax-Induced Bone Growth Retardation in Ex Vivo Cultured Rat Bones.

In vivo/preclinical record. Journal of the Endocrine Society, 2024.

  • Animal
  • 2024

Authorship

Exact sentences from the abstract. No machine-written text is on this page. No person reviewed it.

Source: the abstract of PMID 38328478. Checked Verification: Evidence verified by machine against declared source

This study and its findings belong to the authors cited. Defiance International, a supplier of chemical sequences for research use, keeps this record and makes no claim from its findings.

Verify a lot

Evidence verified by machine against declared source

Open declared source

Key facts

Design
Not reported
System
Animal
Scale
Not published. Nothing is shown here and nothing is substituted for it.
Comparator
None reported
Journal
Journal of the Endocrine Society
Year
2024
PMID
38328478
Verification
Evidence verified by machine against declared source The stored extraction was checked against its declared source. Public summary availability is separate. No tier is an endorsement, an evidence-strength rating, or independent replication, and none establishes efficacy, safety, or suitability.
Full-text availability
Abstract only

Technical summary

Participants or experimental system

Ex vivo studies were performed in fetal rat metatarsal bones and human growth plate samples cultured for 12 and 2 days, respectively, while in vivo studies were performed in young neuroblastoma mice being treated daily for 14 days.

Not reported in the declared source: Methods, Key findings. Not published in this record: Research question, Study design, Study scale, Intervention or exposure, Comparator, Outcomes examined, Key findings.

Limitations and uncertainty

Not published. Nothing is shown here and nothing is substituted for it.

Cite

Cite the study

Humanin Treatment Protects Against Venetoclax-Induced Bone Growth Retardation in Ex Vivo Cultured Rat Bones.
Velentza L, Wickström M, Kogner P et al. Journal of the Endocrine Society. 2024. PMID 38328478. DOI 10.1210/jendso/bvae009

The study and its abstract belong to their authors and publisher. Cite them for anything the study found.

Report an error

If a sentence on this record does not match the abstract, tell us which one. A report starts an automatic re-check by machine. No person reads the record first.

The form takes a sentence and your note. It asks for no name and no address, and we store neither. Do not put personal details in the note.

The report form runs in the interactive page. Open this record with scripts enabled to send a report.

Corrections on this record

No correction has been recorded for this record.

Method sheet

No machine-drafted summary is published on this record. Any section shown is the abstract’s own sentence, printed as issued.